NCT05807776
- Conditions
- Resectable Hepatocellular Carcinoma
- Locations
-
- Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
Resectable Hepatocellular Carcinoma
Explore clinical trials studying Resectable Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.
15 public trials
3 recruiting studies
Resectable Hepatocellular Carcinoma trial results
NCT04701060
- Conditions
- Resectable Hepatocellular Carcinoma
- Locations
-
- Tianjin Medical University Cancer Insititute and Hospital Tianjin, Tianjin Municipality, China
NCT06013657
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Dr. Cipto Mangunkusumo General Hospital Jakarta Pusat, DKI Jakarta, Indonesia
NCT03222076
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
NCT01522820
- Conditions
- Adenocarcinoma, Adnexal Diseases, Anaplastic Astrocytoma, +137 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States